CANbridge
is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and orphan diseases... Read moreCANbridge
is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and orphan diseases... Read more
News
Aug 29, 2024
Marketscreener
CANbridge: CANbridge Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2024
Oct 25, 2023
StreetInsider
Press Release: CANbridge : CANbridge Pharmaceuticals to Present Fabry Disease Gene Therapy Abstract at ESGCT 30th Annual Congress
Oct 18, 2023
Pharmabiz
CANbridge: CANbridge reaches full enrollment in core part of the CAN103 phase 2 trial for Gaucher disease in China
Oct 17, 2023
ChinaBio Today
CANbridge: CANbridge Files Pruritus Therapy NDA for Patients Two Months Old and Up
Oct 10, 2023
Biospectrum Asia
CANbridge: Taiwan approves first and only treatment for rare genetic disorder
Oct 09, 2023
Pharmaceutical Business Review
CANbridge: Taiwan approves CANbridge's CAN108 for treatment of cholestatic pruritus
Sep 06, 2023
StreetInsider
Press Release: CANbridge : CANbridge to Participate in Two Investor Conferences in September
Aug 31, 2023
Yahoo
CANbridge: CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023
Jul 02, 2023
Acrofan
CANbridge: CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committe
Jun 25, 2023
Acrofan
CANbridge: CANbridge Reports Positive Preliminary Data in the Omoprubart (CAN106) Phase 1b Trial in Paroxysmal Nocturnal Hemoglobinuria (PNH) in China
CANbridge Competitors
1
2
3
4
5
6
7
8
9
10